Other Tumors
-
Megace (Megestrol Acetate) – Anorexia | HongKong DengYue Medicine
-
Qingweishi (Everolimus) – Oncology | HongKong DengYue Medicine
-
Hansizhuang (Serplulimab) – Solid Tumors | HongKong DengYue Medicine
-
CIMAher (Nimotuzumab) – HNSCC | HongKong DengYue Medicine
-
Dacogen (Decitabine) – Hematologic Malignancies | HongKong DengYue Medicine
-
Haiyitan (Glumetinib) – Lung Cancer (NSCLC) | HongKong DengYue Medicine
-
Andewei (Benmelstobart) – ES-SCLC | HongKong DengYue Medicine
-
JAKAVI (Ruxolitinib) – MF/GVHD | HongKong DengYue Medicine
-
Qibeian (Iparomlimab Tuvorlimab) – Cervical Cancer | HongKong DengYue Medicine
-
Aitan (Apatinib) – Gastric Cancer | HongKong DengYue Medicine
-
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
-
Orthocone OKT3 (Muromonab-CD3) – Prevention and Treatment of Acute Rejection | HongKong DengYue Medicine
-
Tongao (Calcium Leucovorin) – Folinic Acid Rescue | HongKong DengYue Medicine
-
Zytiga (Abiraterone Acetate) – mCRPC/mCSPC | HongKong DengYue Medicine
-
Valcyte (Valganciclovir) – CMV | HongKong DengYue Medicine
-
Supect (Radotinib) – Ph+ CML | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights